Hotline:
+ 49 (0) 2204 2918806

Market studies for category Infectious Diseases

Items 1 to 10 of 318 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 32
  1. Net price*
    Year
  2. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Pneumocystis Infection - Pipeline Review, H2 2014

    Global Markets Direct
    29 pages
    Global Markets Direct’s, ‘Pneumocystis Infection - Pipeline Review, H2 2014’, provides an overview of the Pneumocystis Infection’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessm
    Englisch | Zukunftsanalyse | SKU: 987671756
  3. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Swine Influenza Global Clinical Trials Review, H2, 2014

    GlobalData
    106 pages
    GlobalData's clinical trial report, “Swine Influenza Global Clinical Trials Review, H2, 2014" provides data on the Swine Influenza clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Swine Influenza. It includes an overview of the trial numbers and their recruitment status as p
    Englisch | Zukunftsanalyse | SKU: 987672110
  4. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Hepatitis A - Pipeline Review, H1 2015

    Global Markets Direct
    33 pages
    Global Markets Direct’s, ‘Hepatitis A - Pipeline Review, H1 2015’, provides an overview of the Hepatitis A’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hepatitis A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of
    Englisch | Zukunftsanalyse | SKU: 987688415
  5. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Infections Caused By Picornaviridae - Pipeline Review, H1 2014

    Global Markets Direct
    36 pages
    Global Markets Direct’s, ‘Infections Caused By Picornaviridae - Pipeline Review, H1 2014’, provides an overview of the Infections Caused By Picornaviridae’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Infections Caused By Picornaviridae, complete with comparative analysis
    Englisch | Zukunftsanalyse | SKU: 394072
  6. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    HIV-1 Infection - Pipeline Review, H1 2014

    Global Markets Direct
    292 pages
    Global Markets Direct’s, ‘HIV-1 Infection - Pipeline Review, H1 2014’, provides an overview of the HIV-1 Infection’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, m
    Englisch | Zukunftsanalyse | SKU: 403913
  7. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Hepatitis D Global Clinical Trials Review, H2, 2014

    GlobalData
    58 pages
    GlobalData's clinical trial report, “Hepatitis D Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis D clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis D. It includes an overview of the trial numbers and their recruitment status as per the site
    Englisch | Zukunftsanalyse | SKU: 987672078
  8. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Human Papillomavirus Infections - Pipeline Review, H1 2015

    Global Markets Direct
    144 pages
    Global Markets Direct’s, ‘Human Papillomavirus Infections - Pipeline Review, H1 2015’, provides an overview of the Human Papillomavirus Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Human Papillomavirus Infections, complete with comparative analysis at various s
    Englisch | Zukunftsanalyse | SKU: 987680139
  9. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Rubella - Pipeline Review, H2 2015

    Global Markets Direct
    48 pages
    Global Markets Direct’s, ‘Rubella - Pipeline Review, H2 2015’, provides an overview of the Rubella’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Rubella, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA)
    Englisch | Marktstudie | SKU: 987689395
  10. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Herpes Simplex Infections - Pipeline Review, H1 2014

    Global Markets Direct
    154 pages
    Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H1 2014’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutic
    Englisch | Zukunftsanalyse | SKU: 393857
  11. $4,995.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - US Drug Forecast and Market Analysis to 2022

    GlobalData
    136 pages
    Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of re
    Englisch | Zukunftsanalyse | SKU: 402435

Items 1 to 10 of 318 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 32